Molecular detection of colorectal cancer (CROSBI ID 789139)
Druge vrste radova | natuknica u enciklopediji, leksikonu, rječniku i sl.
Podaci o odgovornosti
Verbanac, Donatella ; Čeri, Andrea ; Hlapčić, Iva ; Shakibaei, Mehdi ; Brockmueller, Aranka ; Krušlin, Božo ; Ljubičić, Neven ; Baršić, Neven ; Detel, Dijana ; Batičić, Lara ; Rumora, Lada ; Somborac-Bačura, Anita ; Štefanović, Mario ; Ćelap, Ivana ; Demirović, Alma ; Petlevski, Roberta ; Petrik, József ; Grdić Rajković, Marija ; Hulina-Tomašković, Andrea ; Rako, Ivana ; Saso, Luciano ; Barišić, Karmela
engleski
Molecular detection of colorectal cancer
Drug-specific therapeutic approaches for colorectal cancer (CRC) have contributed to a significant improvement in the health status of patients. However, a great need to improve personalization of treatments based on genetic and epigenetic tumor profiles to maximize quality and efficacy while limiting cytotoxicity remains. Currently, CEA and CA 19- 9 are the only validated blood biomarkers in clinical practice. For this reason, laboratories are trying to identify new specific prognostic and, more importantly, predictive biomarkers for CRC patient profiles. Thus, the unique landscape of personalized biomarker data should have a clinical impact on CRC treatment strategies and molecular genetic screening tests should become the standard method for CRC diagnosis, as well as detection of disease progression.
biomarkers ; colorectal cancer ; early detection examination ; liquid biopsy ; personalized medicine ; tumor treatment ; exosomes ; ctDNA ; CTC
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Scholarly community encyclopedia
2021.
nije evidentirano
objavljeno
Povezanost rada
Biologija, Farmacija, Interdisciplinarne prirodne znanosti, Kliničke medicinske znanosti, Temeljne medicinske znanosti